Casandra
Casandra Test Code QD28822Version 1 (DRAFT)
Performing Lab
Lab Quest DiagnosticsLab Test ID 39013
Drug Monitoring, Opioids Panel, With Confirmation, Urine
Also known as: Oxycodone, Morphine, EDDP, Oxymorphone, Naloxone
Clinical Use
Order TestUse
This urine-based diagnostic test panel is designed to detect and confirm the presence of a range of opioids and opioid metabolites. It serves to monitor for exposure or compliance with prescribed opioid medications, as well as the potential misuse of both therapeutic and illicit opioids in a clinical or pain management context.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Not provided.
Biomarkers
8 targets
BuprenorphineFentanylHeroin MetaboliteMethadone MetaboliteMitragynineOpiatesTapentadolTramadol
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
Targeted Opioid Screen, Random, Urine
Mayo Clinic Lab
Opiates, Screen and Confirmation, Urine (Pain Management)
Labcorp
Oxycodone/Oxymorphone, Screen and Confirmation, Urine
Labcorp
Opiates Confirmation, Urine (Labcorp MedWatch®)
Labcorp
Opiates Confirmation, Random, Urine
Mayo Clinic Lab
Oxycodone with Metabolite Confirmation, Random, Urine
Mayo Clinic Lab
Oxycodone/Oxymorphone Confirmation (Labcorp MedWatch®)
Labcorp
Oxymorphone Confirmation, Random, Urine
Mayo Clinic Lab
Opiates Confirmation, Chain of Custody, Random, Urine
Mayo Clinic Lab
Opiates, Urine, Quantitative
ARUP Laboratories